Truncated Rimonabant Study Published - Medscape
Truncated results from rimonabant's large morbidity and mortality study. the trial stopped, but a decision by the EMA tied their clinical hands. Both studies have investigated the safety and efficacy of rimonabant 20 mg in type 2 diabetes mellitus. Furthermore an arm of this clinical trial with an active. Preclinical studies have shown the potential of rimonabant in the specific treatment. Subsequent clinical studies have demonstrated that ri- monabant improves.
Rimonabant - Wikipedia
Rimonabant was an anorectic antiobesity drug that was first approved in Europe in 2006 but. Along with the clinical trials in obesity that generated the data submitted to regulatory authorities, rimonabant was also studied in clinical trials as a. Antagonist, rimonabant SR141716; Acomplia can revolution- ize the ability of the clinicians to manage obesity. Large-scale clinical trials have.